Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon V Tiu

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Leukemia|August 29, 2019
Evaluation of ERK as a therapeutic target in acute myelogenous leukemiaEllen Weisberg, Chengcheng Meng, Abigail Case, et al.
Blood|February 11, 2012
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesisHideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Leukemia|March 8, 2020
Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemiaEllen Weisberg, Chengcheng Meng, Abigail Case, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Journal of Hematology & Oncology|March 23, 2017
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan-Raj, Rafat Abonour, Jonathan W Goldman, et al.
Leukemia & Lymphoma|April 24, 2013
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney diseaseAli Tabarroki, Valeria Visconte, Heesun J Rogers, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
American Journal of Hematology|May 7, 2014
Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10)Valeria Visconte, Ali Tabarroki, Li Zhang, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
JCI Insight|February 23, 2018
Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathwayLakshmi Reddy Palam, Raghuveer Singh Mali, Baskar Ramdas, et al.
American Journal of Hematology|January 23, 2016
Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutationsBetty Ky Hamilton, Valeria Visconte, Xuefei Jia, et al.
Leukemia|August 29, 2019
Evaluation of ERK as a therapeutic target in acute myelogenous leukemiaEllen Weisberg, Chengcheng Meng, Abigail Case, et al.
Blood|February 11, 2012
Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesisHideki Makishima, Valeria Visconte, Hirotoshi Sakaguchi, et al.
Leukemia|March 8, 2020
Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemiaEllen Weisberg, Chengcheng Meng, Abigail Case, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Topography, clinical, and genomic correlates of 5q myeloid malignancies revisitedAndres Jerez, Lukasz P Gondek, Anna M Jankowska, et al.
Journal of Hematology & Oncology|March 23, 2017
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan-Raj, Rafat Abonour, Jonathan W Goldman, et al.
Leukemia & Lymphoma|April 24, 2013
Clinical experiences with ruxolitinib in symptomatic patients with myeloproliferative neoplasm with chronic kidney diseaseAli Tabarroki, Valeria Visconte, Heesun J Rogers, et al.
Blood|February 3, 2011
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignanciesRamon V Tiu, Lukasz P Gondek, Christine L O'Keefe, et al.
American Journal of Hematology|May 7, 2014
Clinicopathologic and molecular characterization of myeloid neoplasms harboring isochromosome 17(q10)Valeria Visconte, Ali Tabarroki, Li Zhang, et al.
Pageof 9